Global Insulin Glargine Market Survey and Trend Research 2018

December 2017 | 91 pages | ID: G53A66293DFEN
99Strategy

Abstracts

Summary

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Sanofi-Aventis, Ganlee, Biocon etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Insulin Glargine Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 INSULIN GLARGINE MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Sanofi-Aventis (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Ganlee (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Biocon (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Insulin Glargine Market 2012-2017, by Type, in USD Million
Table Global Insulin Glargine Market 2012-2017, by Type, in Volume
Table Global Insulin Glargine Market Forecast 2018-2023, by Type, in USD Million
Table Global Insulin Glargine Market Forecast 2018-2023, by Type, in Volume
Table Sanofi-Aventis Overview List
Table Insulin Glargine Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ganlee Overview List
Table Insulin Glargine Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biocon Overview List
Table Insulin Glargine Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Insulin Glargine Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Insulin Glargine Sales Revenue Share, by Companies, in USD Million
Table Global Insulin Glargine Sales Volume 2012-2017, by Companies, in Volume
Table Global Insulin Glargine Sales Revenue Share, by Companies in 2017, in Volume
Table Insulin Glargine Demand 2012-2017, by Application, in USD Million
Table Insulin Glargine Demand 2012-2017, by Application, in Volume
Table Insulin Glargine Demand Forecast 2018-2023, by Application, in USD Million
Table Insulin Glargine Demand Forecast 2018-2023, by Application, in Volume
Table Global Insulin Glargine Market 2012-2017, by Region, in USD Million
Table Global Insulin Glargine Market 2012-2017, by Region, in Volume
Table Insulin Glargine Market Forecast 2018-2023, by Region, in USD Million
Table Insulin Glargine Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Insulin Glargine Industry Chain Structure
Figure Global Insulin Glargine Market Growth 2012-2017, by Type, in USD Million
Figure Global Insulin Glargine Market Growth 2012-2017, by Type, in Volume
Figure Global Insulin Glargine Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Insulin Glargine Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region